Self-assembled lipoplexes of short interfering RNA (sIRNA) using spermine-based fatty acid amide guanidines: Effect on gene silencing efficiency

Pharmaceutics

Volumn 3, Issue 3, 2011, Pages 406-424

  Metwally, Abdelkader A ^a   Blagbrough, Ian S ^a  

^a University of Bath   (United Kingdom)

Author keywords

Fatty acids; Gene silencing; GFP; Guanidine; Lipoplexes; Nanoparticles; Self assembly; siRNA; Spermine

Indexed keywords

GREEN FLUORESCENT PROTEIN; N1,N12 DIAMIDINO N4 LINOLEOYL N9 OLEOYLSPERMINE; N1,N12 DIAMIDINO N4,N9 DIERUCOYLSPERMINE; N1,N12 DIAMIDINO N4,N9 DILAUROYLSPERMINE; N1,N12 DIAMIDINO N4,N9 DIOLEOYLSPERMINE; NANOPARTICLE; SMALL INTERFERING RNA; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG BINDING; DRUG TARGETING; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; ZETA POTENTIAL;

EID: 80053034979     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics3030406     Document Type: Article

References (41)

1. Blagbrough, I.S.; Zara, C. Animal models for target diseases in gene therapy - using DNA and siRNA delivery strategies. Pharm. Res. 2009, 26, 1-18.
2. Fire, A.; Xu, S.Q.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-811.
3. Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411, 494-498.
4. Liu, Q.H.; Paroo, Z. Biochemical principles of small RNA pathways. Annu. Rev. Biochem. 2010, 79, 295-319.
5. Gaynor, J.W.; Campbell, B.J.; Cosstick, R. RNA interference: a chemist's perspective. Chem. Soc. Rev. 2010, 39, 4169-4184.
6. Schroeder, A.; Levins, C.G.; Cortez, C.; Langer, R.; Anderson, D.G. Lipid-based nanotherapeutics for siRNA delivery. J. Intern. Med. 2010, 267, 9-21.
7. Wu, S.Y.; McMillan, N.A.J. Lipidic systems for in vivo siRNA delivery. AAPS J. 2009, 11, 639-652.
8. Tseng, Y.-C.; Mozumdar, S.; Huang, L. Lipid-based systemic delivery of siRNA. Adv. Drug. Deliv. Rev. 2009, 61, 721-731.
9. Mevel, M.; Breuzard, G.; Yaouanc, J.J.; Clement, J.C.; Lehn, P.; Pichon, C.; Jaffres, P.A.; Midoux, P. Synthesis and transfection activity of new cationic phosphoramidate lipids: High efficiency of an imidazolium derivative. ChemBioChem 2008, 9, 1462-1471.
10. Blagbrough, IS.; Metwally, A.A.; Geall, A.J. Measurement of polyamine pKa values. In Polyamines Methods and Protocols; Pegg, A.E., Casero, R.A., Jr., Eds.; Humana Press: New York, NY, USA, 2011; pp. 493-503.
11. Rothbard, J.B.; Jessop, T.C.; Lewis, R.S.; Murray, B.A.; Wender, P.A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 2004, 126, 9506-9507.
12. Wender, P.A.; Galliher, W.C.; Goun, E.A.; Jones, L.R.; Pillow, T.H. The design of guanidinium-rich transporters and their internalization mechanisms. Adv. Drug. Deliv. Rev. 2008, 60, 452-472.
13. Radchatawedchakoon, W.; Watanapokasin, R.; Krajarng, A.; Yingyongnarongkul, B.E. Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery. Bioorg. Med. Chem. 2010, 18, 330-342.
14. Chen, Y.C.; Sen, J.; Bathula, S.R.; Yang, Q.; Fittipaldi, R.; Huang, L. Novel cationic lipid that delivers siRNA andenhances therapeutic effect in lung cancer cells. Mol. Pharm. 2009, 6, 696-705.
15. Santel, A.; Aleku, M.; Keil, O.; Endruschat, J.; Esche, V.; Fisch, G.; Dames, S.; Loffler, K.; Fechtner, M.; Arnold, W.; Giese, K.; Klippel, A.; Kaufmann, J. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Therapy 2006, 13, 1222-1234.
16. Kim, T.I.; Lee, M.; Kim, S.W. A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials 2010, 31, 1798-1804.
17. Bromberg, L.; Raduyk, S.; Hatton, T.A.; Concheiro, A.; Rodriguez-Valencia, C; Silva, M.; Alvarez-Lorenzo, C. Guanidinylated polyethyleneimine-polyoxypropylene-polyoxyethylene conjugates as gene transfection agents. Bioconjug. Chem. 2009, 20, 1044-1053.
18. Theodossiou, T.A.; Pantos, A.; Tsogas, I.; Paleos, CM. Guanidinylated dendritic molecular transporters: prospective drug delivery systems and application in cell transfection. ChemMedChem 2008, 3, 1635-1643.
19. Menuel, S.; Fontanay, S.; Clarot, I.; Duval, R.E.; Diez, L.; Marsura, A. Synthesis and complexation ability of a novel bis-(guanidinium)-tetrakis-(P-cyclodextrin) dendrimeric tetrapod as a potential gene delivery (DNA and siRNA) system. Study of cellular siRNA transfection. Bioconjug. Chem. 2008, 19, 2357-2362.
20. Higashi, T.; Khalil, I.A.; Maiti, K.K.; Lee, W.S.; Akita, H.; Harashima, H.; Chung, S.K. Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery. J. Control. Release 2009, 136, 140-147.
21. Varghese, O.P.; Kisiel, M.; Martinez-Sanz, E.; Ossipov, D.A.; Hilborn, J. Synthesis of guanidinium-modified hyaluronic acid hydrogel. Macromol. Rapid. Commun. 2010, 31, 1175-1180.
22. Vigneron, J.P.; Oudrhiri, N.; Fauquet, M.; Vergely, L.; Bradley, J.C.; Basseville, M.; Lehn, P.; Lehn, J.M. Guanidinium-cholesterol cationic lipids: Efficient vectors for the transfection of eukaryotic cells. Proc. Natl. Acad. Sci. USA 1996, 93, 9682-9686.
23. Metwally, A.A.; Pourzand, C; Blagbrough, IS. Efficient gene silencing by self-assembled complexes of siRNA and symmetrical fatty acid amides of spermine. Pharmaceutics 2011, 3, 125-140.
24. Asasutjarit, R.; Lorenzen, S.I.; Sirivichayakul, S.; Ruxrungtham, K.; Ruktanonchai, U.; Ritthidej, G.C. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro type pHIS-HIV-Hugag transfection. Pharm. Res. 2007, 24, 1098-1107.
25. Feichtinger, K.; Zapf, C.; Sings, H.L.; Goodman, M. Diprotected triflylguanidines: A new class of guanidinylation reagents. J. Org. Chem. 1998, 63, 3804-3805.
26. Feichtinger, K.; Sings, H.L.; Baker, T.J.; Matthews, K.; Goodman, M. Triurethane-protected guanidines and triflyldiurethane-protected guanidines: New reagents for guanidinylation reactions. J. Org. Chem. 1998, 63, 8432-8439.
27. Ross, P.C.; Hui, S.W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Therapy 1999, 6, 651-659.
28. Marchini, C.; Montani, M.; Amici, A.; Amenitsch, H.; Marianecci, C.; Pozzi, D.; Caracciolo, G. Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. Langmuir 2009, 25, 3013-3021.
29. Hoekstra, D.; Rejman, J.; Wasungu, L.; Shi, F.; Zuhorn, I. Gene delivery by cationic lipids: in and out of an endosome. Biochem. Soc. Trans. 2007, 35, 68-71.
30. Lu, J.J.; Langer, R.; Chen, J.Z. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol. Pharm. 2009, 6, 763-771.
31. Jones, L.J.; Yue, S.T.; Cheung, C.Y.; Singer, V.L. RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization. Anal. Biochem. 1998, 265, 368-374.
32. 9-diacyl spermines: Non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery. Pharm. Res. 2009, 26, 19-31.
33. 12-Diacyl spermines: SAR studies on non-viral lipopolyamine vectors for plasmid DNA and siRNA formulation. Pharm. Res. 2010, 27, 17-29.
34. 9-dioctadecanoyl spermines: Nonviral lipopolyamine vectors for more efficient plasmid DNA formulation. Pharm. Res. 2006, 23, 31-40.
35. Gaucheron, J.; Santaella, C.; Vierling, P. Highly fluorinated lipospermines for gene transfer: Synthesis and evaluation of their in vitro transfection efficiency. Bioconjug. Chem. 2001, 12, 114-128.
36. Koynova, R.; Tenchov, B.; Wang, L.; MacDonald, R.C. Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol. Pharm. 2009, 6, 951-958.
37. Han, S.E.; Kang, H.; Shim, G.Y.; Suh, M.S.; Kim, S.J.; Kim, J.S.; Oh, Y.K. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int. J. Pharm. 2008, 353, 260-269.
38. Tagami, T.; Hirose, K.; Barichello, J.M.; Ishida, T.; Kiwada, H. Global gene expression profiling in cultured cells is strongly influenced by treatment with siRNA-cationic liposome complexes. Pharm. Res. 2008, 25, 2497-2504.
39. 9-disubstituted spermines for non-viral siRNA delivery - Structure-activity relationship studies of siFection efficiency versus toxicity. Pharm. Res. 2009, 26, 286-295.
40. Cornish, J.; Callon, K.E.; Lin, C.Q.X.; Xiao, C.L.; Mulvey, T.B.; Cooper, G.J.S.; Reid, I.R. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am. J. Physiol. Endocrinol. Metab. 1999, 277, E779-E783.
41. Patil, S.P.; Yi, J.W.; Bang, E.-K.; Jeon, E.M.; Kim, B.H. Synthesis and efficient siRNA delivery of polyamine-conjugated cationic nucleoside lipids. MedChemComm 2011, 2, 505-508.